Hypertension and medication-related renal dysfunction in the HIV-infected patient

被引:2
作者
Szczech, LA [1 ]
机构
[1] Duke Univ, Med Ctr, Duke Inst Renal Outcomes Res & Hlth Policy, Durham, NC 27710 USA
关键词
D O I
10.1053/snep.2001.23767
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Given the improved life expectancy with highly active antiretroviral therapy among patients with human immunodeficiency virus (HIV)-infection, the treatment of medical problems such as hypertension will become increasingly more important. Although HIV-infected patients are at increased risk for the development of pulmonary hypertension, there is little data to suggest they are at increased risk for systemic hypertension or secondary causes of hypertension. Multiple potential drug interactions exist between antiretroviral medications, particularly the protease inhibitors and antihypertensive medications. Additionally, certain antiretroviral medications have frequent and important side effects relating to the kidneys and urinary system. Knowledge of these interactions and side effects is essential toward caring for the patient with HIV-infection. Copyright © 2001 W.B. Saunders Company.
引用
收藏
页码:386 / 393
页数:8
相关论文
共 51 条
[21]   CRESCENTIC IGA NEPHROPATHY AS A MANIFESTATION OF HUMAN IMMUNE-DEFICIENCY VIRUS-INFECTION [J].
JINDAL, KK ;
TRILLO, A ;
BISHOP, G ;
HIRSCH, D ;
COHEN, A .
AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (02) :147-150
[22]   Protease inhibitors for the treatment of human immunodeficiency virus infection [J].
Kakuda, TN ;
Struble, KA ;
Piscitelli, SC .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (03) :233-254
[23]   Hypertensive crisis secondary to phenylpropanolamine interacting with triple-drug therapy for HIV prophylaxis [J].
Khurana, V ;
de la Fuente, M ;
Bradley, TP .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (01) :118-119
[24]   MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS AND PLEXOGENIC PULMONARY ARTERIOPATHY IN A HOMOSEXUAL MAN WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
KIM, KK ;
FACTOR, SM .
HUMAN PATHOLOGY, 1987, 18 (12) :1293-1296
[25]   Captopril and renal survival in patients with human immunodeficiency virus nephropathy [J].
Kimmel, PL ;
Mishkin, GJ ;
Umana, WO .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (02) :202-208
[26]   HIV-ASSOCIATED IMMUNE-MEDIATED RENAL-DISEASE [J].
KIMMEL, PL ;
PHILLIPS, TM ;
FERREIRACENTENO, A ;
FARKASSZALLASI, T ;
ABRAHAM, AA ;
GARRETT, CT .
KIDNEY INTERNATIONAL, 1993, 44 (06) :1327-1340
[27]   BRIEF REPORT - IDIOTYPIC IGA NEPHROPATHY IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
KIMMEL, PL ;
PHILLIPS, TM ;
FERREIRACENTENO, A ;
FARKASSZALLASI, T ;
ABRAHAM, AA ;
GARRETT, CT .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (10) :702-706
[28]   Indinavir urolithiasis: An emerging cause of renal colic in patients with human immunodeficiency virus [J].
Kohan, AD ;
Armenakas, NA ;
Fracchia, JA .
JOURNAL OF UROLOGY, 1999, 161 (06) :1765-1768
[29]   Crystalluria and urinary tract abnormalities associated with indinavir [J].
Kopp, JB ;
Miller, KD ;
Mican, JAM ;
Feuerstein, IM ;
Vaughan, E ;
Baker, C ;
Pannell, LK ;
Falloon, J .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (02) :119-+
[30]   Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous Cidofovir in cynomolgus monkeys [J].
Lacy, SA ;
Hitchcock, MJM ;
Lee, WA ;
Tellier, P ;
Cundy, KC .
TOXICOLOGICAL SCIENCES, 1998, 44 (02) :97-106